GasderMIN

Contributors: Aude Bernheim

Description

Gasdermin proteins were initially discovered in humans. Recently they were shown to be present in multiple bacteria, where they are almost always encoded in an operon together with a protease. The experimental validation of the antiphage activity of bacterial gasdermins was demonstrated through the heterologous expression of a 4-genes operon from Lysobacter in E. coli (N/A, N/A) .

Molecular Mechanism

Akin to their human counterparts, bacterial gasdermins encode a C-terminal inhibitory domain. Following phage infection, proteases associated with bacterial gasdermin cleave this domain triggering oligomerization of gasdermins into large, membrane-breaching pores (N/A) leading to cell death:ref{doi=10.1101/2023.05.28.542683}. As such gasdermins containing systems are abortive infection systems. rIIB, a protein allowing T6 to overcome the RexAB system was shown to activate gasdermin. It was further shown that CARD domains are also essential in bacterial gasdermins defense (N/A) .

Example of genomic structure

The GasderMIN is composed of 1 protein: bGSDM.

Here is an example found in the RefSeq database:

gasdermin

The GasderMIN system in Flavobacterium johnsoniae (GCF_000016645.1, NC_009441) is composed of 1 protein: bGSDM (WP_012023900.1)

Distribution of the system among prokaryotes

Structure

Experimental validation